PGDM-1400

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NamePGDM-1400
Drug Alias NamePGDM-1400PGDM1400LS
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionRecombinant envelope protein inhibitors
TargetsRecombinant envelope protein
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBotswanaUnited StatesSouth Africa
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInternational Aids Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesOrlando Immunology CenterBeth Israel Deaconess Medical CenterHarvard School Of Public Health +[6] 
Inactive CompaniesHiv Vaccine Trials Network
Active IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A